NanoAssemblr commercial formulation system: Turning industry challenges into innovation 

Listen to the engineers and LNP experts who developed the NanoAssemblr commercial formulation system.
What’s behind their motivation to continually innovate?
Over the last few years, the regulatory and commercial landscape of mRNA-encapsulated lipid nanoparticles has drastically changed. But what's driving this change, and how will it affect the next wave of therapies?
Contact us today to request a quote or learn more at www.cytiva.com/

Наука